The cost of achalasia: quantifying the effect of symptomatic disease on patient cost burden, treatment time, and work productivity.

@article{Nenshi2010TheCO,
  title={The cost of achalasia: quantifying the effect of symptomatic disease on patient cost burden, treatment time, and work productivity.},
  author={Rahima Nenshi and Julie L Takata and Stacey Stegienko and Binu P. Jacob and Paul P. Kortan and Wayne Deitel and Audrey Laporte and Gail Elizabeth Darling and David R. Urbach},
  journal={Surgical innovation},
  year={2010},
  volume={17 4},
  pages={291-4}
}
INTRODUCTION Although the incidence of achalasia is low, the burden of suffering is high because it is a chronic incurable disease that predominantly affects young persons. This article aims to describe the impact of achalasia on health-related quality of life, patient cost burden, time dedicated to treatment, and work productivity. METHODS Consecutive patients enrolled in a clinical trial comparing laparoscopic myotomy with pneumatic dilatation from 4 sites across Canada (whose clinical and… CONTINUE READING